The Accuracy of Multiples Used to Estimate the Market Value of Large U.S. Pharmaceutical Companies
DOI:
https://doi.org/10.33423/jaf.v24i5.7430Keywords:
accounting, finance, pharmaceutical companies, R&Ds, goodwill multipliers, mean absolute deviation, mean square errorAbstract
Many researchers and analysts have shown that expensing R&Ds can distort the profitability measures and market value estimates of R&D intensive firms and treat R&Ds as assets. This paper assesses the valuation accuracy of five goodwill, five enterprise and two price multipliers that can be used to estimate the market values of large U.S. pharmaceutical companies with significant R&D expenditures during the 2010-2022 period. Our results support that goodwill multipliers generally provide the smallest estimation errors of the market values of pharmaceutical firms with significant R&Ds and that gross profit is a superior measure of the profitability of these firms.
References
Alford, A. (1992, Spring). The effect of the Set of Comparable Firms on the Accuracy of the Price-Earnings Valuation Method. Journal of Accounting Research, 30(1), 94–108.
Chari, L., & Bhardwaj, A. (2011). Ascertaining the Best Multiple to Value Pharmaceutical Stocks – An Empirical Study. Retrieved from https://ssrn.com/abstract=2013901.
Damodaran, A. (1998). Value creation and enhancement: Back to the future. Contemporary Finance Digest, 2(4), 5–52.
Danielson, M.G., & Press, E. (2005). When Does R&D Expenses Distort Profitability Estimates? Journal of Applied Finance, 15, 76–92.
Financial Accounting Standards Board. (1974). Statement of financial accounting standards No. 2: Accounting for research and development Costs.
Kaplan, S.N., & Ruback, R. (1995, September). The Valuation of Cash Flow Forecasts: An Empirical Analysis. Journal of Finance, 50(4), 1059–93.
Kim, M., & Ritter, R. (1999, September). Valuing IPOs. Journal of Financial Economics, 53(3), 409–437.
Lie, E., & Lie, H.J. (2002, March–April). Multiples used to estimate corporate value. Financial Analysts Journal, 58(2), 44–54.
McManus, G., Sharma, R., & Tezel, A. (2018). Multiples used to estimate automotive dealerships market value. Business Valuation Review, 37(4), 144–149.
Novy-Marks, R. (2012). The other side of value: The gross profitability premium. Journal of Financial Economics, 103(3), 429–453.
Scherer, F. (1993). Pricing, profits and technology progress in the pharmaceutical industry. Journal of Economic Perspectives, 7(3), 495–504.
Steward, B. (1991, 1999). The Quest for Value. New York: HarperCollins.
